Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neoplasms 1Influenza, Human 1Central Nervous System Neoplasms 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1238Docetaxel 1227Oxaliplatin 1184Capecitabine 1178Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 899Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 640Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × FluMist × Clear all
NCT01474174 2018-07-03

Trivalent Influenza Vaccine in Preventing Flu in Patients With Central Nervous System Tumors

Wake Forest University Health Sciences

Completed
38 enrolled
CNS

Central Nervous System Neoplasms

NCT00906750 2011-10-13

FMRESP

St. Jude Children's Research Hospital

Phase 1 Completed
56 enrolled

Influenza, Human, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡